Inhibition of c-Myc by deguelin in CLL cells shown in this work is an interesting finding in light of its recently described relevance in the metabolic changes that take place in CLL cells upon contact with their tissue microenvironment, changes that promote CLL cell survival and resistance to chemotherapeutic drugs [59]. This evidence concerns the gene MYC and B-cell chronic lymphocytic leukemia.